MCP-1 impacts RCT by repressing ABCA1, ABCG1, and SR-BI through PI3K/Akt posttranslational regulation in HepG2 cells

Journal of Lipid Research

Volumn 54, Issue 5, 2013, Pages 1231-1240

  Huang, Can Xia ^a   Zhang, Yu Ling ^a   Wang, Jing Feng ^a   Jiang, Jie Yu ^a   Bao, Jin Lan ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

ATP binding cassette A1; ATP binding cassette G1; HepG2 cells; High density lipoprotein; Monocyte chemoattractant protein 1; Phosphoinositide 3 kinase Akt pathway; Reverse cholesterol transport; Scavenger receptor class B type I

Indexed keywords

1,1' DIOCTADECYL 3,3,3',3' TETRAMETHYLINDOCARBOCYANINE; ABC TRANSPORTER A1; ABC TRANSPORTER G1; APOLIPOPROTEIN A1; CELL SURFACE RECEPTOR; HIGH DENSITY LIPOPROTEIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SCAVENGER RECEPTOR BI; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; BIOTINYLATION; CELL MIGRATION; CELL STRAIN HEPG2; CELL SURFACE; CELLULAR DISTRIBUTION; CHOLESTEROL METABOLISM; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; GENE SILENCING; LIPID TRANSPORT; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; REVERSE CHOLESTEROL TRANSPORT; TRANSCRIPTION REGULATION;

ATHEROSCLEROSIS; ATP-BINDING CASSETTE TRANSPORTERS; CHEMOKINE CCL2; CHOLESTEROL; ELAFIN; GENE EXPRESSION REGULATION; HEP G2 CELLS; HUMANS; ONCOGENE PROTEIN V-AKT; PROTEIN PROCESSING, POST-TRANSLATIONAL; SCAVENGER RECEPTORS, CLASS B; SIGNAL TRANSDUCTION;

EID: 84876790206     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M032482     Document Type: Article

References (45)

1. Ross, R. 1999. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340: 115-126.
2. Charo, I. F., and R. M. Ransohoff. 2006. The many roles of chemokines and chemokine receptors in inflammation. N. Engl. J. Med. 354 : 610-621.
3. Gawaz, M., F. J. Neumann, T. Dickfeld, W. Koch, K. L. Laugwitz, H. Adelsberger, K. Langenbrink, S. Page, D. Neumeier, A. Schomig, et al. 1998. Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells. Circulation. 98 : 1164-1171.
4. Parissis, J. T., S. Adamopoulos, K. F. Venetsanou, D. G. Mentzikof, S. M. Karas, and D. T. Kremastinos. 2002. Serum profiles of C-C chemokines in acute myocardial infarction: Possible implication in postinfarction left ventricular remodeling. J. Interferon Cytokine Res. 22 : 223-229.
5. Gu, L., Y. Okada, S. K. Clinton, C. Gerard, G. K. Sukhova, P. Libby, and B. J. Rollins. 1998. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptordeficient mice. Mol. Cell. 2 : 275-281.
6. de Lemos, J. A., D. A. Morrow, M. S. Sabatine, S. A. Murphy, C. M. Gibson, E. M. Antman, C. H. McCabe, C. P. Cannon, and E. Braunwald. 2003. Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes. Circulation. 107 : 690-695.
7. Deo, R., A. Khera, D. K. McGuire, S. A. Murphy, P. Meo Neto Jde, D. A. Morrow, and J. A. de Lemos. 2004. Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis. J. Am. Coll. Cardiol. 44 : 1812-1818.
8. Gordon, D. J., J. L. Probstfield, R. J. Garrison, J. D. Neaton, W. P. Castelli, J. D. Knoke, D. R. Jacobs, Jr., S. Bangdiwala, and H. A. Tyroler. 1989. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 79 : 8-15.
9. Assmann, G., and A. M. Gotto, Jr. 2004. HDL cholesterol and protective factors in atherosclerosis. Circulation. 109 : III8-III14.
10. Kontush, A., and M. J. Chapman. 2006. Functionally defective highdensity lipoprotein: A new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol. Rev. 58 : 342-374.
11. von Eckardstein, A., J. R. Nofer, and G. Assmann. 2001. High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport. Arterioscler. Thromb. Vasc. Biol. 21 : 13-27.
12. Tall, A. R. 2008. Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins. J. Intern. Med. 263 : 256-273.
13. Eren, E., N. Yilmaz, and O. Aydin. 2012. High density lipoprotein and it's dysfunction. Open Biochem. J. 6 : 78-93.
14. Khera, A. V., M. Cuchel, M. de la Llera-Moya, A. Rodrigues, M. F. Burke, K. Jafri, B. C. French, J. A. Phillips, M. L. Mucksavage, R. L. Wilensky, et al. 2011. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N. Engl. J. Med. 364 : 127-135.
15. Briel, M., I. Ferreira-Gonzalez, J. J. You, P. J. Karanicolas, E. A. Akl, P. Wu, B. Blechacz, D. Bassler, X. Wei, A. Sharman, et al. 2009. Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: Systematic review and meta-regression analysis. BMJ. 338 : B92.
16. Neufeld, E. B., A. T. Remaley, S. J. Demosky, J. A. Stonik, A. M. Cooney, M. Comly, N. K. Dwyer, M. Zhang, J. Blanchette-Mackie, S. Santamarina-Fojo, et al. 2001. Cellular localization and traffi cking of the human ABCA1 transporter. J. Biol. Chem. 276 : 27584-27590.
17. Santamarina-Fojo, S., A. T. Remaley, E. B. Neufeld, and H. B. Brewer, Jr. 2001. Regulation and intracellular traffi cking of the ABCA1 transporter. J. Lipid Res. 42 : 1339-1345.
18. Shetty, S., E. R. Eckhardt, S. R. Post, and D. R. van der Westhuyzen. 2006. Phosphatidylinositol-3-kinase regulates scavenger receptor class B type I subcellular localization and selective lipid uptake in hepatocytes. Arterioscler. Thromb. Vasc. Biol. 26 : 2125-2131.
19. Lu, R., R. Arakawa, C. Ito-Osumi, N. Iwamoto, and S. Yokoyama. 2008. ApoA-I facilitates ABCA1 recycle/accumulation to cell surface by inhibiting its intracellular degradation and increases HDL generation. Arterioscler. Thromb. Vasc. Biol. 28 : 1820-1824.
20. Wang, N., M. Ranalletta, F. Matsuura, F. Peng, and A. R. Tall. 2006. LXR-induced redistribution of ABCG1 to plasma membrane in macrophages enhances cholesterol mass efflux to HDL. Arterioscler. Thromb. Vasc. Biol. 26 : 1310-1316.
21. Khovidhunkit, W., J. K. Shigenaga, A. H. Moser, K. R. Feingold, and C. Grunfeld. 2001. Cholesterol efflux by acute-phase high density lipoprotein: Role of lecithin: Cholesterol acyltransferase. J. Lipid Res. 42 : 967-975.
22. Feingold, K. R., and C. Grunfeld. 2010. The acute phase response inhibits reverse cholesterol transport. J. Lipid Res. 51 : 682-684.
23. Baranova, I., T. Vishnyakova, A. Bocharov, Z. Chen, A. T. Remaley, J. Stonik, T. L. Eggerman, and A. P. Patterson. 2002. Lipopolysaccharide down regulates both scavenger receptor B1 and ATP binding cassette transporter A1 in RAW cells. Infect. Immun. 70 : 2995-3003.
24. Gerbod-Giannone, M. C., Y. Li, A. Holleboom, S. Han, L. C. Hsu, I. Tabas, and A. R. Tall. 2006. TNFalpha induces ABCA1 through NF-kappaB in macrophages and in phagocytes ingesting apoptotic cells. Proc. Natl. Acad. Sci. USA. 103 : 3112-3117.
25. Khovidhunkit, W., A. H. Moser, J. K. Shigenaga, C. Grunfeld, and K. R. Feingold. 2001. Regulation of scavenger receptor class B type I in hamster liver and Hep3B cells by endotoxin and cytokines. J. Lipid Res. 42 : 1636-1644.
26. Panousis, C. G., and S. H. Zuckerman. 2000. Interferon-gamma induces downregulation of Tangier disease gene (ATP-bindingcassette transporter 1) in macrophage-derived foam cells. Arterioscler. Thromb. Vasc. Biol. 20 : 1565-1571.
27. Witting, S. R., J. N. Maiorano, and W. S. Davidson. 2003. Ceramide enhances cholesterol efflux to apolipoprotein A-I by increasing the cell surface presence of ATP-binding cassette transporter A1. J. Biol. Chem. 278 : 40121-40127.
28. Clément, S., C. Juge-Aubry, A. Sgroi, S. Conzelmann, V. Pazienza, B. Pittet-Cuenod, C. A. Meier, and F. Negro. 2008. Monocyte chemoattractant protein-1 secreted by adipose tissue induces direct lipid accumulation in hepatocytes. Hepatology. 48 : 799-807.
29. Sahoo, D., T. C. Trischuk, T. Chan, V. A. B. Drover, S. Ho, G. Chimini, L. B. Agellon, R. Agnihotri, G. A. Francis, and R. Lehner. 2004. ABCA1-dependent lipid eff lux to apolipoprotein A-1 mediates HDL particle formation and decreases VLDL secretion from murine hepatocytes. J. Lipid Res. 45 : 1122-1131.
30. Tall, A. R., L. Yvan-Charvet, N. Terasaka, T. Pagler, and N. Wang. 2008. HDL, ABC transporters, and cholesterol efflux: Implications for the treatment of atherosclerosis. Cell Metab. 7 : 365-375.
31. Ji, A., J. M. Wroblewski, L. Cai, M. C. de Beer, N. R. Webb, and D. R. van der Westhuyzen. 2012. Nascent HDL formation in hepatocytes and role of ABCA1, ABCG1, and SR-BI. J. Lipid Res. 53 : 446-455.
32. Chen, W., D. L. Silver, J. D. Smith, and A. R. Tall. 2000. Scavenger receptor-BI inhibits ATP-binding cassette transporter 1-mediated cholesterol efflux in macrophages. J. Biol. Chem. 275 : 30794-30800.
33. Ito, J., Y. Nagayasu, A. Kheirollah, S. Abe-Dohmae, and S. Yokoyama. 2011. ApoA-I enhances generation of HDL-like lipoproteins through interaction between ABCA1 and phospholipase C gamma in rat astrocytes. Biochim. Biophys. Acta. 1811 : 1062-1069.
34. Field, F. J., K. Watt, and S. N. Mathur. 2010. TNF-alpha decreases ABCA1 expression and attenuates HDL cholesterol efflux in the human intestinal cell line Caco-2. J. Lipid Res. 51 : 1407-1415.
35. Wang, M. D., V. Franklin, M. Sundaram, R. S. Kiss, K. Ho, M. Gallant, and Y. L. Marcel. 2007. Differential regulation of ATP binding cassette protein A1 expression and ApoA-I lipidation by Niemann-Pick type C1 in murine hepatocytes and macrophages. J. Biol. Chem. 282 : 22525-22533.
36. Vanhaesebroeck, B., P. K. Vogt, and C. Rommel. 2010. PI3K: From the bench to the clinic and back. Curr. Top. Microbiol. Immunol. 347 : 1-19.
37. Burgering, B. M., and P. J. Coffer. 1995. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature. 376 : 599-602.
38. Backer, J. M. 2000. Phosphoinositide 3-kinases and the regulation of vesicular traffi cking. Mol. Cell Biol. Res. Commun. 3 : 193-204.
39. van Dam, E. M., R. Govers, and D. E. James. 2005. Akt activation is required at a late stage of insulin-induced GLUT4 translocation to the plasma membrane. Mol. Endocrinol. 19 : 1067-1077.
40. Turner, S. J., J. Domin, M. D. Waterfield, S. G. Ward, and J. Westwick. 1998. The CC chemokine monocyte chemotactic peptide-1 activates both the class I p85/p110 phosphatidylinositol 3-kinase and the class II PI3K-C2alpha. J. Biol. Chem. 273 : 25987-25995.
41. Wain, J. H., J. A. Kirby, and S. Ali. 2002. Leucocyte chemotaxis: Examination of mitogen-activated protein kinase and phosphoinositide 3-kinase activation by monocyte chemoattractant proteins-1,-2,-3 and-4. Clin. Exp. Immunol. 127 : 436-444.
42. Cai, K., D. Qi, X. Hou, O. Wang, J. Chen, B. Deng, L. Qian, X. Liu, and Y. Le. 2011. MCP-1 upregulates amylin expression in murine pancreatic beta cells through ERK/JNK-AP1 and NF-kappaB related signaling pathways independent of CCR2. PLoS ONE. 6 : E19559.
43. Brunham, L. R., J. K. Kruit, J. Iqbal, C. Fievet, J. M. Timmins, T. D. Pape, B. A. Coburn, N. Bissada, B. Staels, A. K. Groen, et al. 2006. Intestinal ABCA1 directly contributes to HDL biogenesis in vivo. J. Clin. Invest. 116 : 1052-1062.
44. Denis, M., Y. D. Landry, and Z. Xiaohui. 2008. ATP-binding cassette A1-mediated lipidation of apolipoprotein A-I occurs at the plasma membrane and not in the endocytic compartments. J. Biol. Chem. 283 : 16178-16186.
45. Kang, M. H., R. Singaraja, and M. R. Hayden. 2010. Adenosinetriphosphate- binding cassette transporter-1 traffi cking and function. Trends Cardiovasc. Med. 20 : 41-49.